Biology of Blood and Marrow Transplantation
Volume 13, Issue 11 , Pages 1346-1357 , November 2007

Analysis of Hematopoietic Cell Transplants Using Plasma-Depleted Cord Blood Products That Are Not Red Blood Cell Reduced

  • Robert Chow

      Affiliations

    • StemCyte International Cord Blood Center, Arcadia, California
    • StemCyte Taiwan National Cord Blood Center, Linko, Taiwan
    • Corresponding Author InformationCorrespondence and reprint requests: Robert Chow, MD, AM, StemCyte International Cord Blood Center, 1589 West Industrial Park Street, Covina, CA 91722.
    • ,
  • Auayporn Nademanee

      Affiliations

    • City of Hope National Medical Center, Duarte, California
    • ,
  • Joseph Rosenthal

      Affiliations

    • City of Hope National Medical Center, Duarte, California
    • ,
  • Chatchada Karanes

      Affiliations

    • City of Hope National Medical Center, Duarte, California
    • ,
  • Tang-Her Jaing

      Affiliations

    • Chang Gung University and Children’s Hospital, Linko, Taoyuan, Taiwan
    • ,
  • Michael L. Graham

      Affiliations

    • University of Arizona Medical Center, Tucson, Arizona
    • ,
  • Elsa Tsukahara

      Affiliations

    • StemCyte International Cord Blood Center, Arcadia, California
    • ,
  • Brian Wang

      Affiliations

    • StemCyte International Cord Blood Center, Arcadia, California
    • ,
  • David Gjertson

      Affiliations

    • UCLA School of Medicine and UCLA Medical Center, Los Angeles, California
    • UCLA School of Public Health, Los Angeles, California
    • ,
  • Patrick Tan

      Affiliations

    • Mount Elizabeth Hospital, Singapore, Singapore
    • ,
  • Stephen Forman

      Affiliations

    • City of Hope National Medical Center, Duarte, California
    • ,
  • Lawrence D. Petz

      Affiliations

    • StemCyte International Cord Blood Center, Arcadia, California
    • UCLA School of Public Health, Los Angeles, California

Received 8 February 2007 ,Accepted 21 July 2007.

References 

  1. Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med. 2006;57:403–417
  2. Barker J, Krepski TP, DeFor T, Davis S, Wagner J, Weisdorf D. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant. 2002;8:257–260
  3. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343–1347
  4. Creer M, Regan D, Alonso M, Wooford J. Myeloablative single cord transplants (SCT) versus dual cord transplants (DCT) in adults with acute leukemia. Blood. 2005;106:386b
  5. Ballen K, Spitzer TR, Yeap B, et al. Excellent disease-free survival after double cord blood transplantation using a reduced intensity chemotherapy only conditioning regimen in a diverse adult population. Blood. 2005;106:579a–580a
  6. Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant. 2006;38:83–93
  7. Majhail N, Brunstein C, Wagner J. Double umbilical cord blood transplantation. Curr Opin Immunol. 2006;18:1–5
  8. Chow R, Gjertson D, Rosenthal J, et al. Effect of post-thaw washing prior to transplantation of umbilical cord blood units (UCB) that were depleted of plasma but not of red blood cells. Blood. 2005;106:405b
  9. Stiff P, Shane M, Rodriguez T, et al. Successful umbilical cord blood transplants in adults who received a nucleated cell dose = 1 × 107 cells/kg processed by a post-thaw non-wash procedure. Blood. 2005;106:580a
  10. Hahn T, Bunworasate U, George M, et al. Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplant. 2003;32:145–150
  11. Nagamura-Inoue T, Shioya M, Sugo M, et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion. 2003;43:1285–1294
  12. Laroche V, McKenna D, Moroff G, Schierman T, Kadidlo D, McCullough J. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Tranfusion. 2005;45:1909–1946
  13. Fernandez MN, Regidor C, Cabreera R, et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol. 2003;31:535–544
  14. Takahashi T, Rebulla P, Armitage S, et al. Multi-laboratory evaluation of procedures for reducing the volume of cord blood: influence on cell recoveries. Cytotherapy. 2006;8:254–264
  15. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92:10119–10122
  16. Ballen K, Haley R, Kurtzberg J, et al. Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank. Transfusion. 2006;46:2063–2070
  17. Yasutake M, Zheng Y, Inoue-Nagamura I, et al. SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem and/or progenitor cells in a nonobese diabetic/Shi-SCID mice serial xenotransplantation model and immune cell activities in vitro: a comparative study of the filter method and the hydroxyethyl starch method. Transfusion. 2005;45:1899–1908
  18. Lapierre V, Pellegrini N, Bardey I, et al. Cord blood volume reduction using an automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyethyl starch sedimentation) for routine cord blood banking: a comparative study. Cytotherapy. 2007;9:163–169
  19. NMDP Cord Blood Bank Performance data as of June 30, 2006. The NMDP CBB Performance data are provided by the NMDP to the CBB on a quarterly basis as a part of the QA/QC Program.
  20. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–1577
  21. Koegler G, Meyer A, Korschgen L, Platz A, Wernet P. NMDP Council Meeting Abstract. 2005;Abstract 2.
  22. Kernan N, Carter S, Wagner J, et al. Umbilical cord blood transplantation in pediatric patients: results of the Prospective Multi-Institutional Cord Blood Transplantation Study (COBLT). Biol Blood Marrow Transplant. 2006;12(Suppl. 1):14
  23. Kurtzberg J, Carter S, Baxter-Lowe L, et al. Results of the cord blood transplantation study (COBLT): clinical outcome of 193 unrelated donor umbilical cord blood transplantation in pediatric patients with malignant conditions. Biol Blood Marrow Transplant. 2005;11(Suppl. 1):2
  24. Davey S, Armitage S, Rocha V, et al. The London Cord Blood Bank: analysis of banking and transplantation outcome. Br J Hematol. 2004;125:358–365
  25. Lapierre V, Daze B, Rocha V, et al. The French Cord Blood Network: analysis of banking and transplantation outcome. Transfusion. 2005;45(Suppl. 59A):
  26. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood. 2003;101:4233–4244
  27. Kurtzberg J, Lyerly AD, Sugarman J. Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest. 2005;115:2592–2597
  28. Jaing T, Hung I, Yang C, Chen S, Sun C, Chow R. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in five children with beta-thalassemia major. Biol Blood Marrow Transplantat. 2005;11:349–353
  29. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol. 2000;28:1197–1205
  30. Barker JN, Wagner JE. Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol. 2003;48:35–43
  31. Barker JN, Wagner JE. Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol. 2002;14:160–164
  32. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–2285
  33. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–1618
  34. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–2275
  35. Rocha V, Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant. 2006;12(1 Suppl 1):34–41
  36. Rocha V, Sanz G, Gluckman E. Umbilical cord blood transplantation. Curr Opin Hematol. 2004;11:375–385
  37. Goodwin H, Grunzinger L, Regan D, et al. Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential. Cytotherapy. 2004;5:80–86
  38. Chow R, Nademanee A, Rosenthal J, et al. Hematopoietic stem cell transplantation (HSCT) for malignancies using umbilical cord blood units (UCB) that were not red blood cell depleted. Biol Blood Marrow Transplant. 2006;12(Suppl. 1):87
  39. Hung GY, Chiou TJ, Chang CY, Teng HW, Chen PM, Hwang B. Double-unit unrelated cord blood transplantation on chronic myelogenous leukemia. Int J Hematol. 2005;82:159–161
  40. Jaing T, Hung I, Yang C, Lin T, Chow R, Hsieh S. Successful unrelated cord blood transplantation in a child with beta-thalassemia major. J Trop Pediatr. 2005;51:122–124
  41. Jaing T, Rosenthal J, Chow R, et al. Rapid and durable engraftment after unrelated cord blood transplantation (CBT) for children with transfusion-dependent thalassemia. Biol Blood Marrow Transplant. 2006;12(Suppl.):1126–1127
  42. Chow R, Jaing T, Gjertson D, et al. Hematopoietic stem cell transplantation (HSCT) for benign indications using umbilical cord blood units (UCB) that were depleted of plasma (PD) but not of red blood cells. Blood. 2005;106:451b
  43. Chow R, Gjertson D, Rosenthal J, et al. Clinical outcome of hematopoietic stem cell transplantation (HSCT) using plasma depleted umbilical cord blood units (UCB) that were not depleted of red blood cells prior to cryopreservation. Blood. 2005;106:578a
  44. Jaing T, Lee W, Lin T, Huang J, Chen S, Chow R. Successful unrelated mismatched cord blood transplantation in an infant with severe combined immunodeficiency and Mycobacterium bovis bacillus Calmette-Guèrin disease. Pediatr Transplant. 2006;10:1–4
  45. Takahashi S, Iseki T, Ooi J, et al. Single-institution comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813–3820
  46. Windrum P, Morris T, Drake M, Niederwieser D, Ruutu T. EBMT Chronic Leukaemia Working Party Complications Subcommittee (Variations in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centers). Bone Marrow Transplant. 2005;36:601–603
  47. Sauer-Heilborn A, Kadidlo D, McCullough J. Patient care during infusion of hematopoietic progenitor cells. Transfusion. 2004;44:907–916
  48. Rowley SD. Cryopreservation of hematopoietic cells. In:  Blume KG,  Forman SJ,  Appelbaum FR editor. Thomas’ hematopoietic cell transplantation. 3rd ed.. Malden, MA: Blackwell Publishing; 2004;p. 599–612
  49. Petz L. Immunohematologic problems associated with bone marrow transplantation. Transfus Med Rev. 1987;1:85–100
  50. Wagner J, Champlin R, Petz L. Proceedings of the 3rd annual international cord blood transplantation symposium. Biol Blood Marrow Transplant. 2005;11:921–927

PII: S1083-8791(07)00368-0

doi: 10.1016/j.bbmt.2007.07.012

Biology of Blood and Marrow Transplantation
Volume 13, Issue 11 , Pages 1346-1357 , November 2007

Article Tools

* Image Usage & Resolution